Elanco Animal Health Incorporated (ELAN)

NYSE: ELAN · Real-Time Price · USD

25.31

+0.74 (3.01%)

At close: Nov 4, 2026, 4:00 PM EST

25.20

-0.11 (-0.42%)

After-hours: Nov 4, 2026, 7:30 PM EST

Elanco Animal Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	12,645	11,244	5,987	7,343	5,795	13,427
Market Cap Growth	14.91%	87.82%	-18.47%	26.71%	-56.84%	-7.23%
Enterprise Value	16,348	15,063	9,854	12,883	11,233	19,332
Last Close Price	25.31	22.63	12.11	14.90	12.22	28.38

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	17.71	-	-	-
Forward PE	21.42	23.48	13.78	17.64	12.67	24.55
PS Ratio	2.52	2.38	1.35	1.66	1.31	2.82
PB Ratio	1.92	1.72	0.98	1.18	0.80	1.79
P/FCF Ratio	33.37	39.59	15.19	56.05	20.62	41.44
P/OCF Ratio	20.50	20.08	11.07	27.10	12.82	27.80
PEG Ratio	1.95	1.80	1.32	9.57	3.35	0.60

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.26	3.20	2.22	2.92	2.55	4.06
EV/EBITDA Ratio	16.23	16.59	11.21	13.27	11.16	18.59
EV/EBIT Ratio	48.08	58.16	38.34	38.92	28.80	51.41
EV/FCF Ratio	43.14	53.04	25.01	98.34	39.97	59.67

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.64	0.68	0.73	0.95	0.82	0.86
Debt / EBITDA Ratio	3.92	4.53	4.76	5.81	5.65	5.96
Debt / FCF Ratio	11.17	15.65	11.28	45.16	21.27	20.00
Net Debt / Equity Ratio	0.56	0.60	0.65	0.89	0.77	0.78
Net Debt / EBITDA Ratio	3.68	4.30	4.52	5.73	5.59	5.62
Net Debt / FCF Ratio	9.77	13.73	10.09	42.47	20.05	18.03
Asset Turnover	0.37	0.36	0.33	0.30	0.28	0.28
Inventory Turnover	1.30	1.28	1.21	1.18	1.32	1.40
Quick Ratio	0.91	1.00	1.12	1.22	0.90	1.09
Current Ratio	2.05	2.17	2.44	2.75	1.93	1.99
Return on Equity (ROE)	-2.98%	-3.67%	5.49%	-18.22%	-1.05%	-6.04%
Return on Assets (ROA)	1.56%	1.25%	1.19%	1.39%	1.52%	1.38%
Return on Invested Capital (ROIC)	3.29%	2.52%	1.63%	2.68%	2.97%	2.71%
Return on Capital Employed (ROCE)	2.90%	2.20%	2.30%	2.50%	2.80%	2.50%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-1.60%	-2.06%	5.65%	-16.77%	-1.35%	-3.60%
FCF Yield	3.00%	2.53%	6.58%	1.78%	4.85%	2.41%
Buyback Yield / Dilution	0.50%	0.18%	-1.02%	-0.82%	-0.23%	-10.38%

SEC Filings: 10-K · 10-Q